Related Experiment Video
Updated: Mar 18, 2026
05:31
OP-IVM: Combining In vitro Maturation after Oocyte Retrieval with Gynecological Surgery
Published on: May 9, 2021
4.9K
Treating Woman with Myo-Inositol Vaginal Suppositories Improves Partner's Sperm Motility and Fertility
Mario Montanino Oliva1, Roberta Poverini2, Rosella Lisi2
1Department of Obstetrics & Gynecology, Santo Spirito Hospital, 00100 Rome, Italy; IVF Unit, Villa Mafalda Clinic, 00100 Rome, Italy.
International Journal of Endocrinology
|July 13, 2016
Summary
Myo-inositol (MI) vaginal suppositories improved sperm motility and conception rates in couples experiencing fertility issues. This treatment enhanced progressive sperm motility and reduced immotile sperm, aiding fertilization.
Area of Science:
- Reproductive biology
- Infertility research
- Spermatozoa function
Background:
- Sperm motility is crucial for fertilization.
- Decreased sperm motility leads to conception difficulties.
- Myo-inositol (MI) is being investigated for its role in reproductive health.
Purpose of the Study:
- To evaluate the effect of myo-inositol (MI) vaginal suppositories on sperm motility and conception.
- To assess changes in cervical mucus characteristics following MI treatment.
- To determine the impact of MI on male infertility.
Main Methods:
- Fertile women used myo-inositol (MI) vaginal suppositories.
- Sperm motility was assessed in their partners.
- Postcoital tests evaluated cervical mucus and sperm-cervical mucus interaction.
- Pregnancy rates were recorded for enrolled couples.
Main Results:
- MI treatment significantly improved partner's sperm progressive motility.
- A reduction in the percentage of immotile spermatozoa was observed.
- No significant changes in cervical mucus structure or biochemistry were noted.
- Five out of 50 couples conceived during the study period.
Conclusions:
- Myo-inositol (MI) vaginal suppositories can enhance sperm motility and fertility.
- MI may create a favorable cervical mucus environment for spermatozoa.
- MI shows potential for improving male infertility through partner treatment.
Related Concept Videos
01:28Infertility in Females
5.0K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
5.0K
01:23Infertility in Males
655
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
655
01:22Birth Control Methods
7.1K
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
7.1K
01:21Drugs for Treatment of Constipation-Predominant IBS
1.1K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.1K
01:24In Vitro Fertilization
1.3K
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
1.3K
01:21Intrauterine Drug Delivery Systems
101
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
101